Effective management of breast cancer depends on early diagnosis and proper monitoring
of patients' response to therapy. However, these goals are difficult to achieve because of the …

Breast cancer is the second most common cause of deaths reported in women worldwide,
and therefore there is a need to identify breast cancer patients at an early stage as timely …

Simple Summary In the era of precision medicine, new tools for better management of breast
cancer patients are still needed. From this perspective, circulating microRNA (miRNA), a …

MicroRNAs (miRNAs) are master regulators of gene expression. By degrading or blocking
translation of messenger RNA targets, these non-coding RNAs can modulate the expression …

Breast cancer is the second most common malignancy diagnosed in women, supporting the
need for identification of novel prognostic and diagnostic biomarkers. Recently, microRNAs …

Breast cancer (BC) is the most common cancer type and the second cause of cancer-related
death among women. Therefore, better understanding of breast cancer tumor biology and …

Background To date, there are no highly sensitive and specific minimally invasive
biomarkers for detection of breast cancer at an early stage. The occurrence of circulating …

Breast cancer (BC) is the most common malignancy in women. Due to BC heterogeneity,
complexity, and metastasis, many BC patients do not successfully respond to therapies. The …

Introduction MicroRNAs (miRNAs, miRs) are a class of small, non-coding RNA molecules
with relevance as regulators of gene expression thereby affecting crucial processes in …

In recent years, circulating miRNAs have attracted a great deal of attention as promising
novel markers for various diseases. Here, we investigated their potential to serve as …